Dual action of the cannabinoid receptor 1 ligand arachidonyl-2′-chloroethylamide on calcitonin gene-related peptide release

BACKGROUND: Based on the current understanding of the role of neuropeptide signalling in migraine, we explored the therapeutic potential of a specific cannabinoid agonist. The aim of the present study was to examine the effect of the synthetic endocannabinoid (eCB) analogue, arachidonyl-2′-chloroeth...

Descripción completa

Detalles Bibliográficos
Autores principales: Christiansen, Isabella Mai, Edvinsson, Jacob C. A., Reducha, Philip V., Edvinsson, Lars, Haanes, Kristian Agmund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903492/
https://www.ncbi.nlm.nih.gov/pubmed/35189809
http://dx.doi.org/10.1186/s10194-022-01399-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903492/
https://www.ncbi.nlm.nih.gov/pubmed/35189809
http://dx.doi.org/10.1186/s10194-022-01399-8

Ejemplares similares